Format

Send to

Choose Destination
Respir Med Case Rep. 2017 Aug 12;22:179-182. doi: 10.1016/j.rmcr.2017.08.012. eCollection 2017.

Severe pneumocystis jiroveci pneumonia in a patient on temozolomide therapy: A case report and review of literature.

Author information

1
SUNY/Upstate Medical University, USA.

Abstract

A 66 year old man was diagnosed with CNS diffuse large B-cell lymphoma, and underwent treatment with Temozolomide, Dexamethasone, Rituximab, and radiation therapy, and prolonged steroid taper with Dexamethasone. Approximately one month after this, he presented with severe acute hypoxemic respiratory failure, and was admitted to the Medical Intensive Care Unit. Imaging showed diffuse ground glass opacities. Patient underwent diagnostic bronchoalveolar lavage which was positive for Pneumocystis jiroveci. He did not respond well to appropriate therapy and was transitioned to comfort care per his family's wishes, and expired. Pneumocystis jiroveci should always be included in the differential diagnosis of pneumonia in patients treated with Temozolomide, especially when this agent is used in combination with long term, high dose corticosteroids and radiation therapy.

KEYWORDS:

CNS lymphoma; Pneumocystis jiroveci; Temozolomide

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center